Kearney Brian 4
4 · PARDES BIOSCIENCES, INC. · Filed Sep 16, 2022
Insider Transaction Report
Form 4
Kearney Brian
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-14+125,000→ 125,000 totalExercise: $2.98Exp: 2032-09-14→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Options vest over two years with 1/2 of the shares subject to such option vesting and becoming exercisable on September 14, 2023, and the remaining 1/2 of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the 14th day of each month thereafter, subject to continued service relationship.